Agilent has announced that the National Centre for Genome Resources (NCGR) in Santa Fe, New Mexico, has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System.
Agilent has announced that the National Centre for Genome Resources (NCGR) in Santa Fe, New Mexico, has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System.
NCGR now provides Agilent exome and customer target-enrichment services along with sequencing and analysis for a range of genomics studies. To achieve the required status, NCGR had to participate in on-site training and demonstrate a series of skills and expertise.
Callum Bell, NCGR’s vice president for research, said, “SureSelect has contributed significantly to NCGR research efforts already. Achieving CSP status allows us to expand our sequencing menu to offer enrichment of genomic regions in conjunction with next-gen sequencing.”
Fred P. Ernani, PhD, Agilent marketing director, SureSelect NGS platform, commented, “NCGR has a very strong record of accomplishment in the sequencing community and we’re pleased that SureSelect is a key part of its sequencing services.”
Since its introduction three years ago, SureSelect has been instrumental in more than 200 published studies covering research into a range of disorders.
For more information please visit ref="http://www.agilent.com">www.agilent.com
LCGC’s Year in Review: Highlights in Liquid Chromatography
December 20th 2024This collection of technical articles, interviews, and news pieces delves into the latest innovations in LC methods, including advance in high performance liquid chromatography (HPLC), ultrahigh-pressure liquid chromatography (UHPLC), liquid chromatography–mass spectrometry (LC–MS), and multidimensional LC.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.